Isatuximab-Based Triplet Delivered via On-Body System Shows Promise in RRMM: With Xavier Leleu, MD, PhD; and Beth Faiman, PhD, MSN, APN-BC

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.

OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, supported by Sanofi, we had the pleasure of speaking with Xavier Leleu, MD, PhD, and Beth Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, about key data from the phase 3 IRAKLIA study (NCT05405166), which investigated the use of isatuximab-irfc (Sarclisa) plus pomalidomide and dexamethasone administered via an on-body delivery system in patients with relapsed/refractory multiple myeloma. Dr Leleu is a professor, head of the Myeloma Clinic, and head of the Department of Hematology at Hôpital La Mileterie in Poitiers, France. Dr Faiman is a nurse practitioner in the Multiple Myeloma Program at Cleveland Clinic in Ohio.

In our exclusive interview, Drs Leleu and Faiman discussed the unique methods and design of IRAKLIA, key efficacy and safety findings from this trial, and the benefits of using on-body delivery systems to deliver effective therapies to patients in more convenient and patient-centered ways.

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air, supported by Sanofi. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air.